Epithelial-mesenchymal transition in cervical carcinoma

American Journal of Translational Research

Volumn 4, Issue 1, 2012, Pages 1-13

  Lee, Mei Yi ^a   Shen, Meng Ru ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cervical cancer; Epithelial mesenchymal transition; Growth factors; Transcriptional factors

Indexed keywords

HOMEODOMAIN PROTEIN; SRFP1 PROTEIN; SRFP2 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SIX1; TRANSCRIPTION FACTOR TWIST; TUMOR PROMOTER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; ION TRANSPORT; METASTASIS; REVIEW; SNAIL; UTERINE CERVIX CARCINOMA;

GASTROPODA;

EID: 84863011646     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
2. Syrjanen K, Kataja V, Yliskoski M, Chang F, Syrjanen S and Saarikoski S. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol 1992; 79: 675-682.
3. Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10: 445-457.
4. Guck J, Lautenschlager F, Paschke S and Beil M. Critical review: cellular mechanobiology and amoeboid migration. Integr Biol (Camb) 2010; 2: 575-583.
5. Thiery JP, Acloque H, Huang RY and Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
6. Lee JM, Dedhar S, Kalluri R and Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172: 973-981.
7. Kalluri R, Weinberg RA. The basics of epithelialmesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
8. Sleeman JP, Thiery JP. SnapShot: The epithelial -mesenchymal transition. Cell 2011; 145: 162 e1.
9. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
10. Franco DL, Mainez J, Vega S, Sancho P, Murillo MM, de Frutos CA, Del Castillo G, Lopez-Blau C, Fabregat I and Nieto MA. Snail1 suppresses TGF-β-induced apoptosis and is sufficient to trigger EMT in hepatocytes. J Cell Sci 2010; 123: 3467-3477.
11. Baritaki S, Chapman A, Yeung K, Spandidos DA, Palladino M and Bonavida B. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene 2009; 28: 3573-3585.
12. Hsu DS, Lan HY, Huang CH, Tai SK, Chang SY, Tsai TL, Chang CC, Tzeng CH, Wu KJ, Kao JY and Yang MH. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. Clin Cancer Res 2010; 16: 4561-4571.
13. Huber MA, Kraut N and Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-558.
14. Mimeault M, Batra SK. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann Oncol 2007; 18: 1605-1619.
15. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756-3788.
16. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E and Birchmeier W. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the Ecadherin promoter in vivo. Oncogene 1995; 11: 475-484.
17. Peinado H, Olmeda D and Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-428.
18. Lee MY, Chou CY, Tang MJ and Shen MR. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 2008; 14: 4743-4750.
19. Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC and Shen MR. KCl cotransporter- 3 down-regulates E-cadherin/β-catenin complex to promote epithelial-mesenchymal transition. Cancer Res 2007; 67: 11064-11073.
20. Hellner K, Mar J, Fang F, Quackenbush J and Munger K. HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology 2009; 391: 57-63.
21. Geiger T, Sabanay H, Kravchenko-Balasha N, Geiger B and Levitzki A. Anomalous features of EMT during keratinocyte transformation. PLoS One 2008; 3: e1574.
22. Yi JY, Hur KC, Lee E, Jin YJ, Arteaga CL and Son YS. TGFβ1 -mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line. Eur J Cell Biol 2002; 81: 457-468.
23. Veeraraghavalu K, Subbaiah VK, Srivastava S, Chakrabarti O, Syal R and Krishna S. Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1- phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation. J Virol 2005; 79: 7889-7898.
24. Chen YF, Chou CY, Ellory JC and Shen MR. The emerging role of KCl cotransport in tumor biology. Am J Transl Res 2010; 2: 345-355.
25. Shen MR, Chou CY, Hsu KF, Liu HS, Dunham PB, Holtzman EJ and Ellory JC. The KCl cotransporter isoform KCC3 can play an important role in cell growth regulation. Proc Natl Acad Sci USA 2001; 98: 14714-14719.
26. Shin HJ, Rho SB, Jung DC, Han IO, Oh ES and Kim JY. Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion. J Cell Sci 2011; 124: 1077-1087.
27. Srivastava S, Ramdass B, Nagarajan S, Rehman M, Mukherjee G and Krishna S. Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression. Br J Cancer 2010; 102: 196-205.
28. Liao CJ, Wu TI, Huang YH, Chang TC, Wang CS, Tsai MM, Hsu CY, Tsai MH, Lai CH and Lin KH. Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance. Gynecol Oncol 2011; 120: 135-144.
29. Li J, Zhou BP. Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 2011; 11: 49.
30. Shibata K, Kajiyama H, Ino K, Terauchi M, Yamamoto E, Nawa A, Nomura S and Kikkawa F. Twist expression in patients with cervical cancer is associated with poor disease outcome. Ann Oncol 2008; 19: 81-85.
31. Li Y, Wang W, Yang R, Wang T, Su T, Weng D, Tao T, Li W, Ma D and Wang S. Correlation of TWIST2 up-regulation and epithelialmesenchymal transition during tumorigenesis and progression of cervical carcinoma. Gynecol Oncol 2012; 124: 112-118.
32. Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Baron AE, Harrell JC, Horwitz KB, Billheimer D, Heichman KA, Welm AL, Schiemann WP and Ford HL. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling. J Clin Invest 2009; 119: 2678-2690.
33. Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW and Lin YW. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol 2009; 112: 646-653.
34. Liu CY, Chao TK, Su PH, Lee HY, Shih YL, Su HY, Chu TY, Yu MH, Lin YW and Lai HC. Characterization of LMX-1A as a metastasis suppressor in cervical cancer. J Pathol 2009; 219: 222-231.
35. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-166.
36. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J and Garcia De Herreros A. The transcription factor snail is a repressor of E -cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-89.
37. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76-83.
38. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132: 3151-3161.
39. Zweidler-McKay PA, Grimes HL, Flubacher MM and Tsichlis PN. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 1996; 16: 4024-4034.
40. Mingot JM, Vega S, Maestro B, Sanz JM and Nieto MA. Characterization of Snail nuclear import pathways as representatives of C2H2 zinc finger transcription factors. J Cell Sci 2009; 122: 1452-1460.
41. Dominguez D, Montserrat-Sentis B, Virgos-Soler A, Guaita S, Grueso J, Porta M, Puig I, Baulida J, Franci C and Garcia de Herreros A. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol Cell Biol 2003; 23: 5078-5089.
42. Carver EA, Jiang R, Lan Y, Oram KF and Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 2001; 21: 8184-8188.
43. Jiang R, Lan Y, Norton CR, Sundberg JP and Gridley T. The Slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol 1998; 198: 277-285.
44. Emadi Baygi M, Soheili ZS, Schmitz I, Sameie S and Schulz WA. Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines. Cell Biol Toxicol 2010; 26: 553-567.
45. Zha YH, He JF, Mei YW, Yin T and Mao L. Zincfinger transcription factor snail accelerates survival, migration and expression of matrix metalloproteinase-2 in human bone mesenchymal stem cells. Cell Biol Int 2007; 31: 1089-1096.
46. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I and Nieto MA. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004; 18: 1131-1143.
47. Kudo-Saito C, Shirako H, Takeuchi T and Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snailinduced EMT of cancer cells. Cancer Cell 2009; 15: 195-206.
48. Wu Y, Zhou BP. Snail: More than EMT. Cell Adh Migr 2010; 4: 199-203.
49. Peinado H, Ballestar E, Esteller M and Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004; 24: 306-319.
50. Ayyanathan K, Peng H, Hou Z, Fredericks WJ, Goyal RK, Langer EM, Longmore GD and Rauscher FJ 3rd. The Ajuba LIM domain protein is a corepressor for SNAG domain mediated repression and participates in nucleocytoplasmic Shuttling. Cancer Res 2007; 67: 9097-9106.
51. Gotte M, Hofmann G, Michou-Gallani AI, Glickman JF, Wishart W and Gabriel D. An imaging assay to analyze primary neurons for cellular neurotoxicity. J Neurosci Methods 2010; 192: 7-16.
52. Mauhin V, Lutz Y, Dennefeld C and Alberga A. Definition of the DNA-binding site repertoire for the Drosophila transcription factor SNAIL. Nucleic Acids Res 1993; 21: 3951-3957.
53. Ikenouchi J, Matsuda M, Furuse M and Tsukita S. Regulation of tight junctions during the epithelium- mesenchyme transition: direct repression of the gene expression of claudins/ occludin by Snail. J Cell Sci 2003; 116: 1959-1967.
54. Kao YC, Wu LW, Shi CS, Chu CH, Huang CW, Kuo CP, Sheu HM, Shi GY and Wu HL. Downregulation of thrombomodulin, a novel target of Snail, induces tumorigenesis through epithelialmesenchymal transition. Mol Cell Biol 2010; 30: 4767-4785.
55. Porta-de-la-Riva M, Stanisavljevic J, Curto J, Franci C, Diaz VM, Garcia de Herreros A and Baulida J. TFCP2c/LSF/LBP-1c is required for Snail1-induced fibronectin gene expression. Biochem J 2011; 435: 563-568.
56. Moreno-Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez-Pinilla SM, Villa S, Bolos V, Jorda M, Fabra A, Portillo F, Palacios J and Cano A. Genetic profiling of epithelial cells expressing Ecadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelialmesenchymal transition. Cancer Res 2006; 66: 9543-9556.
57. Lan L, Han H, Zuo H, Chen Z, Du Y, Zhao W, Gu J and Zhang Z. Upregulation of myosin Va by Snail is involved in cancer cell migration and metastasis. Int J Cancer 2010; 126: 53-64.
58. Hu CT, Chang TY, Cheng CC, Liu CS, Wu JR, Li MC and Wu WS. Snail associates with EGR-1 and SP-1 to upregulate transcriptional activation of p15INK4b. FEBS J 2010; 277: 1202-1218.
59. Grotegut S, von Schweinitz D, Christofori G and Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 2006; 25: 3534-3545.
60. Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH and Moustakas A. HMGA2 and Smads coregulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 2008; 283: 33437-33446.
61. Bachelder RE, Yoon SO, Franci C, de Herreros AG and Mercurio AM. Glycogen synthase kinase -3 is an endogenous inhibitor of Snail transcription: implications for the epithelialmesenchymal transition. J Cell Biol 2005; 168: 29-33.
62. Evdokimova V, Tognon C, Ng T, Ruzanov P, Melnyk N, Fink D, Sorokin A, Ovchinnikov LP, Davicioni E, Triche TJ and Sorensen PH. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009; 15: 402-415.
63. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M and Hung MC. Dual regulation of Snail by GSK- 3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931-940.
64. MacPherson MR, Molina P, Souchelnytskyi S, Wernstedt C, Martin-Perez J, Portillo F and Cano A. Phosphorylation of serine 11 and serine 92 as new positive regulators of human Snail1 function: potential involvement of casein kinase-2 and the cAMP-activated kinase protein kinase A. Mol Biol Cell 2010; 21: 244-253.
65. Du C, Zhang C, Hassan S, Biswas MH and Balaji KC. Protein kinase D1 suppresses epithelial-tomesenchymal transition through phosphorylation of snail. Cancer Res 2010; 70: 7810-7819.
66. Wu Y, Evers BM and Zhou BP. Small C-terminal domain phosphatase enhances snail activity through dephosphorylation. J Biol Chem 2009; 284: 640-648.
67. Yang Z, Rayala S, Nguyen D, Vadlamudi RK, Chen S and Kumar R. Pak1 phosphorylation of snail, a master regulator of epithelial-tomesenchyme transition, modulates snail's subcellular localization and functions. Cancer Res 2005; 65: 3179-3184.
68. Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D, Csiszar K, Fong KS, Vega S, Nieto MA, Cano A and Portillo F. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J 2005; 24: 3446-3458.
69. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM and Zhou BP. Stabilization of snail by NF-κB is required for inflammation-induced cell migration and invasion. Cancer Cell 2009; 15: 416-428.